WINDTREE THERAPEUTICS INC /DE/ Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Windtree Therapeutics Inc /De/ Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.03M, a 75% increase year-over-year.
  • Windtree Therapeutics Inc /De/ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $11.6M, a 277% increase from 2022.
  • Windtree Therapeutics Inc /De/ annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.08M, a 89.5% decline from 2021.
  • Windtree Therapeutics Inc /De/ annual Net Cash Provided by (Used in) Financing Activities for 2021 was $29.4M, a 47.1% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.03M +$443K +75% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $591K +$680K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 -$89K -$27.7M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $27.6M +$27.8M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 -$199K +$399K +66.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 -$598K -$3.1M -124% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q1 2018 $2.5M -$7.29M -74.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q1 2017 $9.79M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q1 2014 $435K -$9.4M -95.6% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-12
Q1 2013 $9.83M -$40.5M -80.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $50.3M +$27.8M +123% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q1 2011 $22.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.